Here's how NCBI.NLM.NIH.GOV makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NCBI . NLM . NIH . GOV {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Ncbi.nlm.nih.gov Make Money
  6. Keywords
  7. Topics
  8. Social Networks
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. Hosting Providers
  13. CDN Services

We began analyzing https://pubmed.ncbi.nlm.nih.gov/15501983/, but it redirected us to https://pubmed.ncbi.nlm.nih.gov/15501983/. The analysis below is for the second page.

Title[redir]:
Targeting mammalian target of rapamycin synergistically enhances chemotherapy-induced cytotoxicity in breast cancer cells - PubMed
Description:
Rapamycin potentiates the cytotoxicity of selected chemotherapeutic agents in cell lines sensitive to the effects of rapamycin due to aberrations in the phosphatidylinositol 3

Matching Content Categories {📚}

  • Science
  • Health & Fitness
  • Education

Content Management System {📝}

What CMS is ncbi.nlm.nih.gov built with?

Custom-built

No common CMS systems were detected on Ncbi.nlm.nih.gov, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of ncbi.nlm.nih.gov audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Ncbi.nlm.nih.gov Make Money? {💸}

The income method remains a mystery to us.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Ncbi.nlm.nih.gov has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

rapamycin, cancer, doi, pmid, cells, breast, paclitaxel, agents, epub, target, pmc, free, article, protein, kinases, states, articles, mesh, information, res, mammalian, drug, effects, mtor, antineoplastic, pharmacology, nih, main, ncbi, similar, cited, resources, ccr, serinethreonine, therapy, clinical, interactions, resistant, vivo, cell, pathway, pubmed, mar, nov, human, oncol, research, pubchem, hhsunited, hhs,

Topics {✒️}

united states government funding linkout main page content similar articles cited amp-activated protein kinase her2/neu-overexpressing cells literature sources mesh terms antibiotics pubchem substance grants pemetrexed-treated carcinoma cells tumor volume compared research support hhs phosphatidylinositol 3'-kinase/akt pathway health growth-inhibitory effect mesh keyword endometrial cancer cells cultured substances antibiotics antineoplastic antineoplastic agents induced clinical responses clin cancer res paclitaxel act synergistically human services mien-chie hung poorly behaving tumors bae-jump vl rapamycin enhanced chemosensitivity combine endocrine agents undergoing clinical trials curr opin oncol rapamycin increases chemosensitivity cells sensitive carboplatin-induced apoptosis rapamycin-sensitive model rapamycin-sensitive tumors selected chemotherapeutic agents targeting mammalian target breast cancer cell lines sensitive additive effects caski cells rapamycin-mediated chemosensitization promote apoptosis cited cell proliferation synergistic interactions combination therapy mammalian target pubmed wordmark

External Links {🔗}(20)

Analytics and Tracking {📊}

  • Google Analytics
  • Google Analytics 4
  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • jQuery

Emails and Hosting {✉️}

Mail Servers:

  • nihcesxway.hub.nih.gov
  • nihcesxway2.hub.nih.gov
  • nihcesxway3.hub.nih.gov
  • nihcesxway4.hub.nih.gov
  • nihcesxway5.hub.nih.gov

Name Servers:

  • dns1-ncbi.ncbi.nlm.nih.gov
  • dns2-ncbi.ncbi.nlm.nih.gov
  • lhcns1.nlm.nih.gov
  • lhcns2.nlm.nih.gov

CDN Services {📦}

  • Ncbi

3.68s.